Sonia González

Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study

Miguel Martín, Amparo Ruiz Simón, Manuel Ruíz Borrego et al. · Journal of Clinical Oncology · 2015 · 74 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Survival and clinicopathological characteristics of breast cancer patient according to different tumour subtypes as determined by hormone receptor and Her2 immunohistochemistry. A single institution survey spanning 1998 to 2010

Núria Giménez, M. Fraile, Sonia González et al. · The Breast · 2012 · 56 citations · Full text

Medicine, Oncology, Pathology +16

Molar Incisor Hypomineralization in Colombia: Prevalence, Severity and Associated Risk Factors

J Mario Mejia, Manuel Restrepo, Sonia González et al. · Journal of Clinical Pediatric Dentistry · 2019 · 53 citations

Dentistry, Obstetrics, Pediatric Dentistry +13

Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study

Manuel Ruíz‐Borrego, Ángel Guerrero‐Zotano, Begoña Bermejo et al. · Breast Cancer Research and Treatment · 2019 · 23 citations

Medicine, Oncology, Pharmacology +17

Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study

Nerea Fernández de Larrea‐Baz, Beatriz Pérez‐Gómez, Ángel Guerrero‐Zotano et al. · Scientific Reports · 2020 · 20 citations · Full text

Medicine, Oncology, Breast Oncology +16